Immune deviation--the third dimension of nondeletional T cell tolerance.
about
Viral immune evasion due to persistence of activated T cells without effector functionMore stories on Th17 cells.HLA class II restriction of autoreactive T cell responses in pemphigus vulgaris: review of the literature and potential applications for the development of a specific immunotherapy.Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37.Autoimmunity to heat shock protein 60 and antigen-specific production of interleukin-10Hematopoietic chimerism and transplantation tolerance: a role for regulatory T cells.Peptide-based immunotherapy: a novel strategy for allergic disease.Antigen-specific tolerogenic and immunomodulatory strategies for the treatment of autoimmune arthritis.Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift.CD39 and control of cellular immune responses.Immune deviation: a historical perspective.Interleukin-17--extended features of a key player in multiple sclerosis.A self-hsp60 peptide acts as a partial agonist inducing expression of B7-2 on mycobacterial hsp60-specific T cells: a possible mechanism for inhibitory T cell regulation of adjuvant arthritis?Selective accumulation of type 1 effector cells expressing P-selectin ligand and/or alpha(4)beta(7)-integrin at the lesions of autoimmune gastritis.Tumour-induced polarization of tumour vaccine-draining lymph node T cells to a type 1 cytokine profile predicts inherent strong immunogenicity of the tumour and correlates with therapeutic efficacy in adoptive transfer studies.
P2860
Q24646943-CBE66C9E-6DCA-44A9-B998-0028963EBAE1Q33728334-3F83F936-D5E4-4B8D-ADFA-85A5C3F1EF91Q33751646-510EE4D5-CEF3-487B-8F43-5FF6F09CA9F7Q34341797-57DAE42D-C251-4632-9EC9-6562427BE789Q35546321-A6F31D87-91FA-42E0-A4F1-4E7ED724360EQ35928393-3985C23E-B4B1-45A2-BC09-9C9212CDADD8Q36350581-0C1EA15B-7DDE-4807-8273-585A77DBF1FCQ37051562-5FB09700-5168-49EE-AFB0-A26A1DE5FF04Q38975096-EB303909-5D5A-4279-89C9-82626E626F92Q40730152-699FFF9F-51EA-4317-AC3C-A3CAC9FBC261Q41205466-55C97E50-9B95-4F46-A358-257358FF8A92Q42940067-97F21B63-535F-4E31-9804-236A7B596350Q44803445-4741E43F-38E5-4A20-97DE-5788BDD86B01Q52014822-FA2D4D12-C183-48C6-AB8A-0EDCA3CA4EB3Q52948843-9AE97D56-DE50-4860-9565-5825526298F5
P2860
Immune deviation--the third dimension of nondeletional T cell tolerance.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Immune deviation--the third dimension of nondeletional T cell tolerance.
@en
type
label
Immune deviation--the third dimension of nondeletional T cell tolerance.
@en
prefLabel
Immune deviation--the third dimension of nondeletional T cell tolerance.
@en
P2860
P1476
Immune deviation--the third dimension of nondeletional T cell tolerance.
@en
P2093
P2860
P304
P356
10.1111/J.1600-065X.1996.TB00904.X
P577
1996-02-01T00:00:00Z